News SCD Co., Ltd.

Equities

A042110

KR7042110007

End-of-day quote Korea S.E. Other stock markets 23:00:00 13/05/2024 BST			5-day change	1st Jan Change
1,484 ^KRW	+1.92%		-1.13%	-15.35%

04-03	Schroder European Real Estate Investment Trust Refinances EUR9 Million Loan	MT
02-01	SeaStar Medical Gets Canadian Patent Covering Technology for Cell-Directed Therapy	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Schroder European Real Estate Investment Trust Refinances EUR9 Million Loan	04-03	MT
SeaStar Medical Gets Canadian Patent Covering Technology for Cell-Directed Therapy	02-01	MT
SeaStar Medical's Selective Cytopheretic Device Considered Approvable by the US FDA for Pediatric AKI and Sepsis Treatment	03/10/23	MT
Schroder European Real Estate Investment Trust Posts Lower Property Portfolio Valuation as of June 30	17/07/23	MT
Schroder European Real Estate Investment Trust Swings to Fiscal H1 Loss	28/06/23	MT
SCD Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Sector Update: Health Care Stocks Slipping Wednesday Afternoon	10/05/23	MT
SeaStar Medical Holding Shares Drop After US FDA Rejects Application for Pediatric Selective Cytopheretic Device	10/05/23	MT
Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group	12/04/23	RE
Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group	12/04/23	RE
Schroder European Real Estate Investment Trust Posts Lower FY22 NAV	23/03/23	MT
Schroder European Real Estate Investment Trust Buys EUR11 Million Warehouse in Netherlands	20/03/23	MT
China Fines Five Banks 388 Million Yuan Over Irregularities	20/02/23	MT
SeaStar Medical Shares Rise 20% After FDA Grants IDE Application	09/02/23	DJ
National Bank Begins Coverage on Lycos Energy	19/12/22	MT
Graphite Bio Gets Fast Track Designation for GPH101 Sickle Cell Treatment	03/05/22	DJ
Editas Medicine Secures FDA Rare Pediatric Disease Designation for EDIT-301 for Beta Thalassemia	26/04/22	MT
Global Blood Therapeutics's Oxbryta Gets European Approval for Treatment of Hemolytic Anemia in Patients With SCD	16/02/22	MT
Bluebird Bio Shares Drop 20% After Partial Clinical Hold for Patients Under 18 in Sickle Cell Gene Therapy Program	20/12/21	DJ
Global Blood Therapeutics Wins US FDA Nod for Expanded Indication of Oxbryta in Children	17/12/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News SCD Co., Ltd.

Equities

A042110

KR7042110007

Summary

Filters